Rationale: Diaphragm weakness acquired in the intensive care unit plays an important role in difficult weaning from mechanical ventilation. However, whether contractile weakness of diaphragm muscle fibers develops in mechanically ventilated critically ill patients is unknown. Objective: To determine (1) the contractile strength of diaphragm muscle fibers from mechanically ventilated critically ill patients, and (2) test the ability of the fast skeletal troponin activator, CK-2066260, to improve contractile strength.
Introduction
Diaphragm weakness in the intensive care unit (ICU) plays an important role in difficult weaning from mechanical ventilation. Diaphragm strength in mechanically ventilated (MV) critically ill patients has been assessed indirectly using phrenic nerve stimulation, which demonstrated that the pressure generating capacity of the diaphragm was reduced in these patients 62, 63, 123 . However, this technique cannot distinguish between impaired phrenic nerve function, abnormal neuromuscular transmission, or intrinsic abnormalities in the diaphragm muscle itself. Consequently, it is unknown whether intrinsic contractile weakness of diaphragm muscle fibers occurs in MV critically ill patients. If so, targeted treatment strategies that enhance contractility may improve the success of weaning. Such treatment strategies may include the administration of a novel class of small molecule drugs named fast skeletal troponin activators, which improve the contractile strength of skeletal muscle fibers 81 . In this study, we obtained diaphragm biopsy specimens from critically ill patients (n=10; mechanically ventilated for 28-603 hours) undergoing laparotomy or thoracotomy, and compared them with control patients undergoing elective lung surgery (n=10; mechanically ventilated 1-2 hours, Table 1 ). The size and the contractile performance of isolated diaphragm muscle fibers were determined. In addition, we tested the ability of the fast skeletal troponin activator, CK-2066260, to improve contractile strength.
Results

Patients
The demographic and clinical characteristics of critically ill and control patients are shown in Table 1 and 2. Control and critically ill patients were mechanically ventilated for, on average, 1.6±0.4 and 210±185 hours, respectively. The control and critically ill group did not significantly differ with respect to age (57±13 vs. 52±13 years, respectively, p=0.47), body mass index (25±3 vs. 24±5 kg/m 2 , respectively, p=0.72) or gender (male/female: 4/6 vs. 6/4, p=0.66) We measured the contractile performance of permeabilized single diaphragm fibers isolated from the biopsy specimens. Fibers were mounted between a force transducer and a length motor, and exposed to activating calcium solutions. Compared to controls, the maximal absolute force-determined at maximally activating calcium concentrations (pCa 4.5) -was reduced by 56% in slow-twitch (controls vs ICU 0.44±0.16 mN vs. 0.19±0.07 mN, p<0.0001) and by 52% in fast-twitch (controls vs ICU 0.49 ±0.21 mN vs. 0.24 ± 0.09 mN, p=0.0002) diaphragm fibers from critically ill patients. In addition, we measured the sensitivity of force to calcium. The pCa50 (i.e. the negative logarithm of the calcium concentration needed to obtain 50% of maximal force) was unaffected in slow-twitch fibers (control 5.64±0.03 vs. critically ill 5.61±0.08, p=0.30), whereas in fast-twitch fibers the pCa50 was significantly lower in critically ill patients (controls 5.76±0.07 vs. critically ill 5.70±0.06, p=0.036). 
ICU
. (A) Severe diaphragm muscle fiber weakness in mechanically ventilated critically ill patients. Curves indicate the absolute force-calcium relation of diaphragm fibers of control and MV critically ill patients. Compared to controls, the maximal absolute force was reduced by 56% in slowtwitch and by 52% in fast-twitch diaphragm fibers of critically ill patients (B) Indents show calcium sensitivity (pCa50). In slow-twitch fibers, pCa50 is not affected (left panel), whereas in fast-twitch fibers pCa50 was significantly lower in critically ill patients (right panel). Bullets and column bars indicate group mean, error bars indicate ± SD.
By normalizing absolute force to the cross sectional area of each fiber, maximal specific force was obtained (figure 3). Compared to controls, slow-twitch fibers of critically ill patients had 17% lower specific force, control vs. critically ill respectively 114±21 mN/mm2 vs. 95±26 mN/mm2, p=0.049 and fast-twitch fibers of critically ill patients were 20% lower, respectively 147±28 mN/mm2 vs. 118±38 mN/mm2, p=0.030. These findings suggests that in these critically ill patients there is not only a loss of contractile proteins, but also dysfunction of the remaining ones and that fast-twitch diaphragm fibers also require more calcium to generate force. We exposed diaphragm fibers of a representative subset of control (#I, IV, VI) and critically ill patients (#1, 3, 4, 5) to the fast skeletal troponin activator CK-2066260, which improves the sensitivity of the calcium sensor in the muscle sarcomere. We verified that the subset of patients were representative for the group by means of comparing the force responses to calcium in the diaphragm fibers from the subset of control patients to all control patients and by comparing the subset of critically ill patients to all critically ill patients: the force response to calcium in the subset of control patients was not significantly different from all control patients (p=0.9994). Also the force response to calcium in the subset of critically ill patients was not different in from all critically ill patients (p= 0.9833) (see figure 4a ). To determine a concentration-force response curve for the fast skeletal troponin activator CK-2066260, single diaphragm fibers from control patients were exposed to pCa solutions of 5.8 -this pCa typically yielded ~40% of maximal active force -with increasing concentrations (1, 2, 5, 10 and 20 μM) of CK-2066260 dissolved in 1% dimethylsulfoxide (DMSO) as vehicle (see figure  4b ). CK-2066260 enhanced submaximal force generation with a maximal effect at 5 μM therefore we used a concentration of 5μM CK-2066260 to determine the potential of CK-2066260 to improve force generation in diaphragm fibers. Note that 1% DMSO did not affect muscle fiber contractility (data not shown). Note that no difference in fiber type proportion (percentage slow-twitch fibers in control patients 49±10 % vs. critically ill patients 48±6 %, p=0.825) or in fiber type area fraction (percentage slowtwitch in control patients 53±12 % vs. critically ill patients 54±10 %, p=0.875) was observed (see figure 5). Compared to vehicle, 5μM of CK-2066260 significantly increased the calcium sensitivity of diaphragm fibers both in controls (pCa50: 5.75±0.04 vs. 6.18±0.1, respectively, p<0.001) and in critically ill patients (5.70±0.07 vs. 6.00±0.13, respectively, p<0.01) (see figure 6) . Importantly, at physiological calcium concentrations, CK-2066260 restored the contractile force of fast-twitch diaphragm fibers of critically ill patients back to levels observed in untreated fibers from controls (force at pCa 5.8: untreated controls 0.22±0.05 vs. treated critically ill 0.22±0.07 mN, p=0.954). The magnitude of increase in pCa50 upon exposure to 5μM CK-2066260 was comparable in both groups. 
Figure 4 (A) Curves
Figure 6. The curves show force response of fast-twitch fibers of a subset of patients to incremental calcium concentrations when exposed to vehicle (DMSO) (control grey solid line, critically ill black solid line). Fibers from critically ill patients show a marked leftward shift of the force-calcium
when treated with 5μM CK-2066260 (dotted black line), such that at physiological calcium concentration (indicated by grey bar) force is restored to levels observed in untreated fibers from controls.. Bullets indicate group mean, error bars indicate ± SD.
Discussion
The current study is the first to show that atrophy and contractile weakness of diaphragm muscle fibers develop in a clinically relevant group of mechanically ventilated critically ill patients. Interestingly, the reduction in the contractile force of diaphragm fibers of these critically ill patients is comparable to the reduction in diaphragm strength estimated previously by phrenic nerve pacing 62, 63 , indicating that the reduction in diaphragm strength in these patients largely results from muscle fiber weakness. To date, no drug is approved to improve respiratory muscle function in MV critically ill patients. We made a step towards such a strategy by testing the ability of the fast skeletal troponin activator, CK-2066260, to restore diaphragm fiber strength. We observed that upon exposure to CK-2066260, fast-twitch diaphragm fibers from critically ill patients regained strength at calcium concentrations which reflect activation during daily live activities to levels found in untreated fibers from control patients (Fig.1c) . Since ~50% of fibers and total fiber area in the human diaphragm consists of fast-twitch fibers (eFig.3), fast skeletal troponin activators might significantly improve in vivo diaphragm strength. The potential of fast troponin activators is further strengthened by the notion that these drugs do not affect cardiac function 81 , which would be an undesirable side effect in critically ill patients. The analogue of CK-2066260, tirasemtiv (formerly CK-2017357) is currently under study in patients with amyotrophic lateral sclerosis [NCT01709149].
What causes weakness of diaphragm muscle fibers in critically ill patients? It seems plausible that the observed diaphragm weakness was acquired during ICU-stay, as we used strict exclusion criteria to rule out that our study patients had pre-existing diaphragm weakness. Also, during stay in the ICU, patients received nutrition according to an optimized nutrition algorithm 124 . A commonly suggested concept is that mechanical ventilation per se rapidly induces weakness and atrophy of muscle fibers due to contractile inactivity of the diaphragm 40, 56, 64, 68, 125 . The critically ill patients we studied received MV for 28-603 hours prior to biopsy, a time frame that was associated with significant reductions in the CSA of diaphragm fibers in brain dead organ donors 68, 69 . Thus, the diaphragm muscle fiber atrophy and weakness that we observed may, at least partly, be explained by mechanical ventilation per se. Other ICU related phenomena that could contribute to diaphragm muscle weakness include underlying disease such as sepsis 126, 127 . Clearly, to elucidate the main factors that contribute to the observed diaphragm muscle fiber weakness requires studies with larger cohorts of various patient groups.
Methods
Patients
Diaphragm biopsy specimens were obtained from mechanically ventilated critically ill patients (n=10) undergoing laparotomy or thoracotomy for various reasons. Diaphragm biopsies obtained from patients undergoing thoracotomy for removal of a primary lung tumor served as controls (n=10). Exclusion criteria were COPD (GOLD II, III, IV), CHF, neuromuscular disease, chronic metabolic disorders, pulmonary hypertension, chronic use of corticosteroids (>7.5 mg/day for at least 3 months), and >10% weight loss within the last 6 months. The biopsy protocol was approved by the institutional review board at VU University Medical Center (#2010/69) and written informed consent was obtained from the patient, next of kin, or a legal representative.
Biopsy handling
A small part of the fresh biopsy was directly frozen in liquid nitrogen and stored at -80°C for histology experiments. The other part of the biopsy -destined for contractility experiments -was placed for 24h at -20°C in 4 mL relax-glycerol solution containing high concentrations of protease inhibitors (RxGlychigh); for the composition of solutions, see below. Subsequently, the biopsy was placed on a roller band for 24h at 4°C. Finally, RxGlychigh was substituted with a relax-glycerol solution with lower concentrations of protease inhibitors (RxGlyc, for composition, see below) and stored at -20°C until further use.
Solution composition
Composition of solutions for contractility experiments was as described previously 82, 92, 94 . All solutions had an ionic strength of 180mM and pH 7.1. The relaxing solution had a negative logarithm of free calcium concentration (pCa) of 9.0 and comprised of (in mM): 5.89 Na2ATP, 6.48 MgCl2, 40.76 Kprop, 100 BES, 6.97 EGTA, 14.50 CrP and low concentration of freshly added protease inhibitors. Pre-activating solutions consisted of (in mM): 5.87 Na2ATP, 0.1 EGTA, 6.42 MgCl, 41.14 Kprop, 100 BES, 14.50 CrP and 6.9 HDTA. Activating solutions consisted of (in mM) 5.97 Na2ATP, 7.0 CaEGTA, 6.28 MgCl, 40.64 Kprop, 100 BES and 14.50 CrP. By accurate mixing of relaxing solutions and maximal activating solutions, sub-maximal activating solutions with pCa 7, 6.2, 5. 
Contractility experiments
For contractility experiments an adapted protocol from Ottenheijm et al. was used, as described previously. 90 Segments of single diaphragm fibers of approximately 1-1.5 mm were isolated in a relaxing solution at 5°C. At both ends, two aluminium clips were attached. The diaphragm fibers were incubated for 10 minutes in cold (5°C) skinning solution to permeabilize the plasma membrane enabling activation of myofilaments with exogenous calcium. Subsequently, the fibers were mounted horizontally on two stainless-steel hooks in a relax solution filled chamber (200 μL) with a glass coverslipbottom on the stage of an inverted microscope (Zeiss, The Netherlands). One of hooks was attached to a force transducer (model 403A Aurora Scientific Inc, Ontario, Canada) which has a resonance frequency of 10 kHz, whereas the other end was attached to a servo-motor (model 315C, Aurora Scientific Inc.; Aurora, Ontario, Canada) which has a step time of 250 μs. Diaphragm fiber dimensions were measured by means of a camera device coupled to the objective. Diaphragm fiber length was determined with 100x magnification, depth and width were measured with 400x magnification (an elliptical cross section of the diaphragm muscle fiber was assumed). Injury was examined microscopically; in case of severe damage, loss of striation and other irregularities the fibers were excluded. Diaphragm fibers were stretched to optimal length by setting sarcomere length at 2.5 μm with dedicated Aurora software. To ensure stable attachment of the diaphragm fiber in the clips throughout the mechanical protocol, the fiber was briefly maximally activated prior to the experiment, and when necessary restreched to sarcomere length 2.5μm. Note that this brief activation was done before the determination of diaphragm fiber dimensions. To determine the force response of single diaphragm fibers to calcium (force-pCa relation (pCa = -log of molar free Ca 2+ concentration), fibers were sequentially transferred from relax, to pre-activation solutions and finally to solutions with pCa values ranging from 4.5 to 9.0 and the steadystate force was measured. The Hill-equation was fit to the obtained force-pCa data, providing the pCa50.During the experiment, data were automatically collected by a data acquisition board (sampling rate 10000 Hz). All measurements were performed at 20°C.
Myosin Heavy Chain Isoform Composition
At the end of the contractile experiments, Myosin Heavy Chain (MHC) isoform composition of the single diaphragm fiber were identified by SDS-PAGE as described previously with minor modifications 90 . Briefly, single diaphragm fiber were detached from the force transducer and servo-motor and placed in 25 µl of SDS sample buffer containing 62.5 mM Tris.HCL, 2% (wt/vol) SDS, 10% (vol/vol) glycerol, and 0.001% (wt/vol) bromophenol blue at a pH of 6.8 and stored at -20°C until assayed. The stacking gel contained 4% acrylamide pH 6.8 and the separating gel 7% at pH 8.8 with 30% glycerol (v/v). Prior to gel electrophoresis, the samples were denaturated by boiling for 2 min. Loaded sample volumes were 10 µL per lane. We used human reference samples of diaphragm bundles in a 1:200 dilution of SDS sample buffer (~9.0 ng/µL) to asses migration patterns and verify isoforms of the myosin heavy chain. The gels were silver stained with alkaline phosphatase (VectastainABC kit, Vector Labs) according to the procedure described by Oakley et al E100 and subsequently imaged by a high-resolution scanner (600 dpi; Microtek Scan Maker 5). Fibers expressing the slow isoform were classified as slow-twitch fibers and fibers expressing the 2a and 2x isoform were classified as fast-twitch fibers.
Immunohistology
To determine diaphragm fiber cross sectional area, immunohistochemical analyses with myosin heavy chain antibodies were performed on cryosections of the biopsy specimens, as decscrebid previously 83, 102 . Cryosections were cut from the frozen biopsies (perpendicular to diaphragm fiber direction, 8µm thick), rehydrated for 10 min in phosphate buffer (PBS) and subsequently blocked with phosphate buffer containing 0.5% (wt/vol) bovine serum albumin (PBS-0.5%BSA, Molecular Probes). Subsequently, cryosections were incubated with primary antibodies for slow MHC (1:100; NOQ7.5.4D, Abcam) and for fast MHC (1:50 MY-32, Abcam) followed by appropriate fluorescent labelled secondary antibodies (Molecular Probes, Eugene, OR). Finally plasma membranes were visualized by embedding the sections in fluorescent WGA (1:25 diluted in PBS-0.5%BSA, Molecular Probes) which selectively recognizes sialic acid and N-acetylglycosaminyl sugar residues. Following each incubation, cryosections were washed three times for 3 min with PBS. Samples were washed and protected with a layer of Vector Shield and a cover glass. 
Statistical analysis
Fisher's exact test and unpaired t-test were used for patient characteristics when appropriate. Comparisons of contractile parameters and fiber cross sectional areas between groups were performed using multilevel analysis with correction for nonindependence of successive measurements per subject (MLwiN, 2.22) 87, 128, 129 . We performed two-way repeated measurement ANOVA to study fiber type proportion, and fiber type area and in CK-2066260 experiments to study pCa50 and whether the subset of patients was representative. To compare the force response at pCa5.8 in CK-2066260 experiments unpaired t-test was used. Differences were attributed to chance unless they were significant at the 0.05 level. Data in text and in figures are represented as mean±SD.
